Kemwell Announces Successful USFDA Inspection at Bangalore Facility
Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017
Press Releases 1 - 1 of 1